Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini …
K Sato, Y Niimi, R Ihara, K Suzuki… - Journal of …, 2024 - content.iospress.com
Background: Primary outcome measure in the clinical trials of disease modifying therapy
(DMT) drugs for Alzheimer's disease (AD) has often been evaluated by Clinical Dementia …
(DMT) drugs for Alzheimer's disease (AD) has often been evaluated by Clinical Dementia …
[HTML][HTML] Effect of memory therapy on enhancing postoperative cognitive function recovery and alleviating mood disturbances in brain glioma patients
Y Wu, J Han, R Li, J Chen, S Mao… - American Journal of …, 2024 - ncbi.nlm.nih.gov
Objective: To assess the impact of memory therapy on enhancing recovery of postoperative
cognitive function and alleviating mood disturbances in brain glioma patients. Methods: This …
cognitive function and alleviating mood disturbances in brain glioma patients. Methods: This …
Usability of the Mayo Test Drive remote self-administered web-based cognitive screening battery in adults ages 35 to 100 with and without cognitive impairment
JS Patel, TJ Christianson, LT Monahan, RD Frank… - medRxiv, 2024 - medrxiv.org
Background. Self-administered cognitive screening measures that can be completed
unsupervised and remotely have significant promise for high scalability. Mayo Test Drive …
unsupervised and remotely have significant promise for high scalability. Mayo Test Drive …
[HTML][HTML] Effective Connectivity of Default Mode Network Subsystems in Parkinson's Disease with Mild Cognitive Impairment Based on Spectral Dynamic Causal …
TT Pan, H Qu, Y Pan, W Wang, Y Zhao - Journal of Integrative …, 2024 - imrpress.com
Objective: The objective of this study is to compare the differences in effective connectivity
within the default mode network (DMN) subsystems between patients with Parkinson's …
within the default mode network (DMN) subsystems between patients with Parkinson's …